HomeNXG • CVE
add
NexgenRx Inc
Previous close
$0.35
Day range
$0.35 - $0.37
Year range
$0.24 - $0.45
Market cap
26.31M CAD
Avg Volume
20.87K
P/E ratio
21.97
Dividend yield
2.70%
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 4.62M | 13.43% |
Operating expense | 3.24M | 8.09% |
Net income | 589.78K | 295.22% |
Net profit margin | 12.78 | 248.23% |
Earnings per share | — | — |
EBITDA | 922.43K | 93.18% |
Effective tax rate | -4.03% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.54M | 37.80% |
Total assets | 39.20M | 24.07% |
Total liabilities | 30.91M | 31.59% |
Total equity | 8.29M | — |
Shares outstanding | 71.12M | — |
Price to book | 3.83 | — |
Return on assets | 4.07% | — |
Return on capital | 17.68% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 589.78K | 295.22% |
Cash from operations | 880.82K | 600.83% |
Cash from investing | -55.65K | 40.55% |
Cash from financing | -417.40K | -13,852.92% |
Net change in cash | 407.77K | 1,061.12% |
Free cash flow | 623.53K | 4,905.04% |
About
Founded
2003
Headquarters
Website
Employees
20
